UBS Vitainvest is selling at 157.96 as of the 1st of January 2025; that is No Change since the beginning of the trading day. The fund's open price was 157.96. UBS Vitainvest has hardly any chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 2nd of December 2024 and ending today, the 1st of January 2025. Click here to learn more.
Although UBS Vitainvest's alpha and beta are two of the key measurements used to evaluate UBS Vitainvest's performance over the market, the standard measures of volatility play an important role as well.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with UBS Vitainvest fund to make a market-neutral strategy. Peer analysis of UBS Vitainvest could also be used in its relative valuation, which is a method of valuing UBS Vitainvest by comparing valuation metrics with similar companies.